Skip to Content
Find More Like This
Return to Search

Biomarkers for liver fibrosis

United States Patent

September 15, 2015
View the Complete Patent at the US Patent & Trademark Office
Pacific Northwest National Laboratory - Visit the Technology Commercialization Program Website
Methods and systems for diagnosing or prognosing liver fibrosis in a subject are provided. In some examples, such methods and systems can include detecting liver fibrosis-related molecules in a sample obtained from the subject, comparing expression of the molecules in the sample to controls representing expression values expected in a subject who does not have liver fibrosis or who has non-progressing fibrosis, and diagnosing or prognosing liver fibrosis in the subject when differential expression of the molecules between the sample and the controls is detected. Kits for the diagnosis or prognosis of liver fibrosis in a subject are also provided which include reagents for detecting liver fibrosis related molecules.
Jacobs; Jon M. (Pasco, WA), Burnum-Johnson; Kristin E. (Richland, WA), Baker; Erin M. (West Richland, WA), Smith; Richard D. (Richland, WA), Gritsenko; Marina A. (Richland, WA), Orton; Daniel (Pasco, WA)
Battelle Memorial Institute (Richland, WA)
14/ 209,860
March 13, 2014
ACKNOWLEDGMENT OF GOVERNMENT SUPPORT This invention was made with government support under 5P41RR018522-10 awarded by the National Institutes of Health's National Center for Research Resources, under 8 P41 GM103493-10 awarded by the National Institute of General Medical Sciences, under R21-CA12619-01 and U24-CA-160019-01 awarded by the National Cancer Institute, and DE-AC05-76RLO01830 awarded by the Department of Energy. The Government has certain rights in the invention.